Back

Mapping breast cancer lineage in radiation and immunotherapy using the REMAP mouse

Marshall, A. C.; Vahey, J.; Bagheri, M.; Saxe, R.; Fields, J.; Kolling, F. W.; McKenna, A.

2026-04-18 cancer biology
10.64898/2026.04.15.718689 bioRxiv
Show abstract

We present REMAP (Recording Evolution in Mammary tumors via Active PyMT), a lineage-tracing mouse model that integrates inducible CRISPR recording with the MMTV-PyMT model of hormone receptor-positive (HR+) breast cancer. Inducible Cas9 drives editing of MARC1 homing guide RNAs (hgRNAs), generating heritable lineage marks, and enables reconstruction of clonal relationships. Using REMAP, we profiled tumor evolution and response to radiation combined with anti-PD1 immunotherapy. Treatment reduced tumor burden locally and systemically, and single-cell RNA sequencing revealed remodeling of the tumor microenvironment (TME). We identified metastatic clones present across primary tumors and distant sites, which exhibited elevated epithelial-mesenchymal transition (EMT) programs as a heritable clonal state. Treatment reduced EMT-associated transcriptional programs and reshaped immune composition, with radiation driving clonal expansion of T cells and reduced repertoire diversity. In contrast, cancer-associated fibroblast clones spanned multiple transcriptional states, indicating substantial stromal plasticity. Together, REMAP enables high-resolution coupling of clonal history and cellular state in vivo, revealing that tumor progression, metastasis, and therapeutic response are governed by heritable lineage programs.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 7%
21.6%
Similar papers in this journal
2
Cancer Research
● 130 papers in training set
Top 0.5%
6.2%
Similar papers in this journal
3
Cell Reports
○ 1498 papers in training set
Top 8%
4.8%
Similar papers in this journal
4
Science Advances
● 1243 papers in training set
Top 7%
4.3%
Similar papers in this journal
5
Cancer Research Communications
● 51 papers in training set
Top 0.2%
4.0%
Similar papers in this journal
6
Nature Cancer
○ 39 papers in training set
Top 0.5%
3.4%
7
Nature Biotechnology
○ 172 papers in training set
Top 1%
3.2%
8
eLife
● 5828 papers in training set
Top 36%
3.2%
50% of probability mass above
9
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 18%
3.1%
10
Scientific Reports
○ 3612 papers in training set
Top 37%
2.7%
11
Nature Methods
○ 385 papers in training set
Top 3%
2.7%
12
Breast Cancer Research
○ 36 papers in training set
Top 0.2%
2.7%
13
Cell Reports Medicine
○ 153 papers in training set
Top 2%
2.4%
14
Communications Biology
○ 993 papers in training set
Top 14%
1.7%
15
Nature
○ 645 papers in training set
Top 7%
1.5%
16
Cancer Discovery
● 66 papers in training set
Top 1%
1.5%
17
Clinical Cancer Research
● 64 papers in training set
Top 1%
1.5%
18
Cell
○ 431 papers in training set
Top 7%
1.3%
19
Genes & Development
● 90 papers in training set
Top 1%
1.3%
20
iScience
○ 1154 papers in training set
Top 27%
1.1%
21
Genome Medicine
○ 183 papers in training set
Top 4%
1.1%
22
Nature Genetics
○ 286 papers in training set
Top 4%
1.1%
23
Molecular Cancer Research
● 49 papers in training set
Top 1%
1.1%
24
JCI Insight
● 277 papers in training set
Top 7%
1.0%
25
Genome Biology
○ 637 papers in training set
Top 8%
1.0%
26
Cancers
○ 213 papers in training set
Top 5%
0.8%
27
Cell Genomics
○ 172 papers in training set
Top 4%
0.8%
28
NAR Cancer
◐ 37 papers in training set
Top 0.8%
0.8%
29
Nucleic Acids Research
◐ 1281 papers in training set
Top 14%
0.8%
30
npj Breast Cancer
○ 23 papers in training set
Top 0.4%
0.8%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.